Last update 21 Nov 2024

BMS-986408

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
DGKA x DGKζ
Mechanism
DGKA inhibitors(diacylglycerol kinase alpha inhibitors), DGKζ inhibitors(diacylglycerol kinase zeta inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Bristol-Myers Squibb Pharmaceuticals Ltd.
Active Organization
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC27H31F3N6O
InChIKeyMVPFPBIHUUHXGU-FSSWDIPSSA-N
CAS Registry2618418-12-3

Related

1
Clinical Trials associated with BMS-986408
NCT05407675 / Active, not recruitingPhase 1/2
A Phase 1/2 Study of BMS-986408 Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
100 Clinical Results associated with BMS-986408
Login to view more data
100 Translational Medicine associated with BMS-986408
Login to view more data
100 Patents (Medical) associated with BMS-986408
Login to view more data
100 Deals associated with BMS-986408
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
FR
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
02 Aug 2022
Advanced Malignant Solid NeoplasmPhase 2
US
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
02 Aug 2022
Advanced Malignant Solid NeoplasmPhase 2
CA
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
02 Aug 2022
Advanced Malignant Solid NeoplasmPhase 2
ES
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
02 Aug 2022
Advanced Malignant Solid NeoplasmPhase 2
CH
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
02 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free